J. Wanninger

发表

Adiponectin, a key adipokine in obesity related liver diseases.

C. Buechler, J. Wanninger, M. Neumeier, 2011, World journal of gastroenterology.

Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity

C. Buechler, J. Wanninger, M. Neumeier, 2009, European journal of clinical investigation.

Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes

J. Schölmerich, Sabrina Bauer, C. Buechler, 2010, Clinical endocrinology.

Reduced response to adiponectin and lower abundance of adiponectin receptor proteins in type 2 diabetic monocytes

C. Buechler, J. Wanninger, M. Neumeier, 2008, FEBS letters.

Adiponectin receptor binding proteins – recent advances in elucidating adiponectin signalling pathways

C. Buechler, J. Wanninger, M. Neumeier, 2010, FEBS letters.

Metformin reduces cellular lysophosphatidylcholine and thereby may lower apolipoprotein B secretion in primary human hepatocytes.

J. Schölmerich, G. Schmitz, C. Buechler, 2008, Biochimica et biophysica acta.

Adiponectin downregulates galectin‐3 whose cellular form is elevated whereas its soluble form is reduced in type 2 diabetic monocytes

C. Buechler, J. Wanninger, M. Neumeier, 2009, FEBS letters.

Annexin A6 protein is downregulated in human hepatocellular carcinoma

C. Buechler, Kristina Eisinger, G. Liebisch, 2016, Molecular and Cellular Biochemistry.

Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release.

G. Schmitz, C. Buechler, G. Liebisch, 2007, Biochemical and biophysical research communications.

Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes.

J. Schölmerich, Sabrina Bauer, C. Buechler, 2010, The Journal of clinical endocrinology and metabolism.

Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease

G. Rogler, J. Schölmerich, Sabrina Bauer, 2010, Inflammatory bowel diseases.

Elevated free fatty acids and impaired adiponectin bioactivity contribute to reduced SOD2 protein in monocytes of type 2 diabetes patients.

Sabrina Bauer, C. Buechler, J. Wanninger, 2011, Experimental and molecular pathology.

Adiponectin upregulates monocytic activin A but systemic levels are not altered in obesity or type 2 diabetes.

J. Schölmerich, C. Buechler, J. Wanninger, 2009, Cytokine.

Low-abundant adiponectin receptors in visceral adipose tissue of humans and rats are further reduced in diabetic animals.

Sabrina Bauer, C. Buechler, J. Wanninger, 2010, Archives of medical research.

Annexin A6 is highly abundant in monocytes of obese and type 2 diabetic individuals and is downregulated by adiponectin in vitro

C. Buechler, J. Wanninger, M. Neumeier, 2009, Experimental & Molecular Medicine.

Adiponectin-stimulated CXCL 8 release in primary human hepatocytes is regulated by ERK 1 / ERK 2 , p 38 MAPK , NF-B , and STAT 3 signaling pathways

J. Schölmerich, Sabrina Bauer, C. Buechler, 2009 .

Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-kappaB, and STAT3 signaling pathways.

J. Schölmerich, Sabrina Bauer, C. Buechler, 2009, American journal of physiology. Gastrointestinal and liver physiology.

Adiponectin upregulates hepatocyte CMKLR1 which is reduced in human fatty liver

C. Hellerbrand, Sabrina Bauer, C. Buechler, 2012, Molecular and Cellular Endocrinology.

Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes

C. Hellerbrand, Sabrina Bauer, C. Buechler, 2011, FEBS letters.

Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes.

C. Hellerbrand, J. Schölmerich, Sabrina Bauer, 2011, Biochimica et biophysica acta.

Detection of adiponectin in cerebrospinal fluid in humans.

J. Schölmerich, C. Buechler, J. Wanninger, 2007, American journal of physiology. Endocrinology and metabolism.

MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis.

C. Hellerbrand, Sabrina Bauer, C. Buechler, 2011, Experimental and molecular pathology.

Systemic resistin is increased in type 2 diabetic patients treated with loop diuretics.

Sabrina Bauer, C. Buechler, J. Wanninger, 2011, Journal of diabetes and its complications.

Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver.

C. Buechler, Kristina Eisinger, T. Weiss, 2013, Experimental and molecular pathology.

Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes.

C. Hellerbrand, Sabrina Bauer, C. Buechler, 2011, Endocrinology.

Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis.

J. Schölmerich, Sabrina Bauer, C. Buechler, 2011, Cytokine.

Adiponectin Isoforms Differentially Affect Gene Expression and the Lipidome of Primary Human Hepatocytes

C. Buechler, Kristina Eisinger, G. Liebisch, 2014, Metabolites.

Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function.

C. Hellerbrand, Sabrina Bauer, C. Buechler, 2011, Cytokine.

Lipidomic analysis of the liver identifies changes of major and minor lipid species in adiponectin deficient mice.

G. Schmitz, Sabrina Bauer, C. Buechler, 2013, Experimental and molecular pathology.

Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease.

C. Buechler, Kristina Eisinger, T. Weiss, 2013, Experimental and molecular pathology.

Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis.

C. Hellerbrand, J. Schölmerich, Sabrina Bauer, 2011, Experimental and molecular pathology.

Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis

C. Buechler, G. Liebisch, T. Weiss, 2022, Molecular and Cellular Biochemistry.

Chemerin Is Induced in Non-Alcoholic Fatty Liver Disease and Hepatitis B-Related Hepatocellular Carcinoma

C. Buechler, T. Weiss, J. Wanninger, 2020, Cancers.

Insulin induces monocytic CXCL8 secretion by the mitogenic signalling pathway.

J. Schölmerich, C. Buechler, J. Wanninger, 2008, Cytokine.

Portal levels of latent transforming growth factor-&bgr; are related to liver function in patients with liver cirrhosis

Sabrina Bauer, C. Buechler, Kristina Eisinger, 2011, European Journal of Gastroenterology and Hepathology.

Annexin A6 protein is downregulated in human hepatocellular carcinoma

C. Buechler, Kristina Eisinger, G. Liebisch, 2016, Molecular and Cellular Biochemistry.